THE IMPORTANCE OF CLINICAL PHARMACY IN THE MONITORING OF PATIENTS WITH LEPROSY IN A PRIMARY CARE CLINIC

• Autor(a) principal: Silva, Amanda de Souza
• Data de Publicação: 2015
• Tipo de documento: Artigo
• Idioma: por
• Título da fonte: Hansenologia Internationalis (Online)
• Texto Completo: https://periodicos.saude.sp.gov.br/hansenologia/article/view/35003
• topic: Atenção Farmacêutica; Assistência Farmacêutica; Hanseníase; Educação em Saúde; Pharmaceutical Services; Pharmaceutical Care; Leprosy; Health Education

Introduction: Leprosy, with an average of 47,000 new cases registered each year, is endemic in Brazil. Clinical pharmacy, an activity developed by the pharmacist in the pharmacotherapeutic followup of patients, is used to monitor adverse events, study possible interactions and propose therapeutic regimens to attain better results. Objective: To describe the implementation of a clinical pharmacy in leprosy patients at a government health clinic in Sao Paulo. Methods: The Dader method was applied to obtain obtaining the pharmacotherapeutic history of patients and an assessment of their condition was made to identify and resolve possible negative medication-related outcomes. Results: Most of the 25 patients were male, Caucasian, aged 40-59 years old and with no more than four years of schooling. Conclusion: All patients had negative medicationrelated outcomes. Fifty pharmaceutical interventions were necessary with the most common being adjustments to the drug administration time and guidance on non-pharmacological measures.